Antonio Cuneo

18PUBLICATIONS
112CO-AUTHORS
Condensed matter characterisation technique developmentCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 11, 2026
Minimal residual disease in CLL: when does it really matter?

|Mar 28, 2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Stefano Molica, Potito Rosario Scalzulli, Lydia Scarfò

|Jan 23, 2026
Exploring the synergy between telomere length and genomic complexity in CLL.

Silvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso

|Jun 13, 2025
18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study.

Fabiana Esposito, Luigi Manco, Luca Urso

|Apr 16, 2025
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort.

Andrea Serafin, Alessandro Cellini, Enrica Antonia Martino

|Mar 14, 2025
Assessing the economic burden of Waldenström's Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL), and Chronic Lymphocytic Leukemia (CLL).

Matteo Scortichini, Martina Paoletti, Angela Ragonese

Pageof 3

Frequent Collaborators

5 joint publications

Gian Matteo Rigolin

5 joint publications

Luca Laurenti

4 joint publications

Francesco Albano

3 joint publications

Fabrizio Pane